Sherry Chou, MD, MMSc, was been selected to receive the Neurocritical Care Society’s 2019 Investing in Clinical Neurocritical Care Research (INCLINE) Grant, announced at the Society’s annual meeting in Vancouver on October 15. She will use the $100,000 grant for a one-year project entitled, MicroRNA Biomarkers of Systemic Inflammation and Outcome in Subarachnoid Hemorrhage.
“This award will allow me to extend my current R21 study from a single- to a multi-center project and generate preliminary data for future larger multi-center grant proposals,” explained Dr. Chou, who is an associate professor of Critical Care Medicine, Neurology and Neurosurgery in the Department of Critical Care Medicine at the University of Pittsburgh.
Dr. Chou’s research interests include subarachnoid hemorrhage, ischemic stroke and traumatic brain injury, recovery after subarachnoid hemorrhage, and neurological critical care. She received her MD from McGill University and completed a residency in Neurology and a fellowship in Neurocritical Care and Vascular Neurology at Brigham and Women’s Hospital, Massachusetts General Hospital. She also holds a Diploma in Leadership from Harvard Business School.
The INCLINE Grant is a research grant opportunity for members of the Neurocritical Care Society to foster promising and innovative, collaborative, multi-center research. The grant provides one year of funding for collaborative pilot studies in neurocritical care that will enable the awardee to develop preliminary data to submit a formal proposal to national funding agencies such as the NIH, Department of Defense, PCORI, etc. The Neurocritical Care Society promotes research in neurocritical care through the creation of the Neurocritical Care Research Network (NCRN), and through funded research fellowships.